You are here

Teva wins US nod for Actavis after divestiture of 79 drugs


THE US Federal Trade Commission (FTC) has approved Teva Pharmaceutical Industries Ltd's US$40.5 billion purchase of Allergan Plc's generic drug-making unit after the companies agreed to the biggest divestiture ever in a pharmaceutical merger to preserve competition.


BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to